Human Microbiota Transfer HMT (also known as fecal microbiota transplant FMT) is a therapy which transfers gut microbes from a healthy human donor to a patient. In this process, we collect fecal matter from rigorously screened donors and extract the healthier microbes for transplant by medical clinicians into unhealthy patients. Our goal is to make this breakthrough HMT therapy available to patients in a safer, cheaper, and standarized format.
Human Microbiota Transfer has been used for decades, and in the past several years has been the subject of many scientific studies which have demonstrated this therapy's astonishing positive results. Especially in the case of recurrent or severe Clostridium Difficile infection (CDI), doctors have achieved cure rates of more than 80 percent according to the American College of Gastroenterology. This is roughly 3x higher than the leading pharmaceutical alternative. Currently, studies are ongoing to deterimine the effectiveness of HMT for other gastro-intenstinal diseases, including Crohn's disease, ulcerative colitis, and irritable bowel syndrome (IBS).
For further information about published studies visit our Scientific Research page.